undamentalytics Newsletter
Sign in

Innovex International, Inc. (INVX) stock

Add to watchlist

Add holding +

NYSE: INVX NYSE Oil & Gas Equipment & Services Next results ~January 25, 2027

Innovex International, Inc. is a US-listed company in the oil & gas equipment & services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Innovex International, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Innovex International files

Where Innovex International stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $998m, up 15.0% on a year earlier, slower than the 28.0% growth a quarter earlier. Free-cash-flow margin fell to 9.4% from 11.4% a year earlier. Operating margin widened to 10.0% from 6.7%. It passes 6 of our 6 financial-health checks.

Our model value for Innovex International is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 25, 2027 (estimated)

Innovex International, Inc.'s trailing-twelve-month revenue grew 15.0% year on year, with a free-cash-flow margin of 9.4%.

Our discounted-cash-flow model values the business at ~$56 per share in the base case (~$43–$72 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 4.5% while net income fell 57.4%: a 53pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 15.0% over the last 12 months.
  • Margins widening. Operating margin is up 3.3 points on a year ago.
  • Shrinking share count. Diluted shares fell 2.0% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.2bn.

Things to watch

  • Growth slowing. The growth rate is 13.0 points lower than a quarter earlier.
  • Insiders selling. 6 insiders sold $615M of stock over the past 365 days and none bought (50% under pre-set trading plans).

Latest results: FY2026 Q2

Filed August 4, 2026
Earnings per share
$0.41 against an average estimate of $0.40: beat by 2.5%
Revenue
$245m, up 9.2% on a year earlier
Share reaction
-7.5% in the first session after the results on October 29, 2026, against -2.1% for the S&P 500
Next report
October 29, 2026; average EPS estimate $0.41

Innovex International's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-7.2%
  • 1 week-15.0%
  • 1 month-4.6%
  • This year+19.1%
  • 1 year+29.8%
  • 5 years+8.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$998M
Operating margin
10.0%
Net margin
6.2%
EPS (TTM, diluted)
$0.89

Growth

Revenue growth
+15.0%
Change in growth rate
−13.0 pts

Cash

Free cash flow (TTM)
$94.2M
FCF margin
9.4%
Stock pay % of revenue
1.5%

Earnings

Last results
October 29, 2026
Next results (est.)
January 25, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Agreement
  3. Insider trade
  4. Insider trade
  5. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Innovex International, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Innovex International, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.2%: the 10-year Treasury yield (4.9%) plus a beta of 0.94 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$26 ~$24–$33 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$18 ~$12–$27 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$18 ~$15–$21 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Innovex International, Inc. with Oil & Gas Equipment & Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$59.23$60.05$47.70$30.03$46.91$29.62$19.68$27.17$23.27$13.97$21.87$26.05
Market value$2.3bn$2.3bn$1.8bn$1.1bn$1.7bn$1.0bn$695m$854m$753m$707m$1.5bn$1.8bn
+ Net debt (− = net cash)−$381m−$423m−$493m−$418m−$399m−$346m−$355m−$259m−$137m−$38m−$178m−$197m
Enterprise value$1.9bn$1.8bn$1.3bn$695m$1.3bn$698m$340m$595m$616m$669m$1.3bn$1.6bn
Multiples
Price / sales 2.7x4.2x3.9x2.9x4.1x2.9x2.2x2.4x1.8x1.1x1.6x1.8x
Price / earnings 11.9x24.3x——n/m——13.5x10.2x5.0x18.2x29.3x
Price / free cash flow 14.0x10.2x22.2x82.8xn/m—24.5x—17.4x7.6x7.9x11.5x
EV / EBITDA 6.8x12.7x——35.2x——6.3x5.1x8.3x6.9x9.9x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

34 /100

Weak moat

How hard Innovex International's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 1 / 20

    Cash operating profit has been a median 2.5% of total assets over 10 years.

  • Pricing power 4 / 20

    Gross margin has been a median 28.5%, moving by 8.6 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -3.7%; its worst year was -27.4%.

  • Cash conversion 10 / 20

    Free cash flow was positive in 7 of 10 years, at a median 6.7% of revenue.

  • Discipline 9 / 20

    The diluted share count rose 91.6% over five years; stock-based pay has been a median 3.1% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.41 +34% $1.0bn +5%
Next $1.88 +33% $1.1bn +10%

Next year's EPS estimate has moved −3.9% in 90 days, across 5 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.5% on 90 days ago. In the last 30 days, 1 analyst raised Innovex International, Inc.'s forecast and 2 cut it.

Consensus EPS forecast Innovex International, Inc., last 90 days
$1.40 $1.60 $1.80 $2.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.42 Current fiscal year, 60 days ago: $1.54 Current fiscal year, 30 days ago: $1.54 Current fiscal year, 7 days ago: $1.54 Current fiscal year, Now: $1.41 $1.41 Next fiscal year, 90 days ago: $1.95 Next fiscal year, 60 days ago: $1.87 Next fiscal year, 30 days ago: $1.87 Next fiscal year, 7 days ago: $1.87 Next fiscal year, Now: $1.88 $1.88

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.42$1.95
60 days ago $1.54$1.87
30 days ago $1.54$1.87
7 days ago $1.54$1.87
Now $1.41$1.88

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $0.40 $0.41 +2.5%
Jun 2026 $0.30 $0.31 +1.1%
Mar 2026 $0.25 $0.34 +33.6%
Dec 2025 $0.31 $0.24 −20.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

6 analysts, Oct 2026
Buy467%
Hold233%
Sell00%

Monthly trend

  1. Oct 20261326
  2. Sep 20261315
  3. Aug 20261315
  4. Jul 20261315

Counts of recommendations published by analysts covering Innovex International, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
7.7%
of tradable shares
Days to cover
4.14
at average volume
Short interest, 1 month
+3%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
1.6%
of shares
Employees
2,160
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +29.8%

$20.07 on October 31, 2025 to $26.05

ThenNowEffect
Revenue (last 12 months) $867m $998m +15.0%
Net margin 16.7% 6.2% −63.0%
P/E multiple 7.4x 29.3x +297.7%
Share count 53m 69m −23.4%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
INVX−34%+38%−14%−40%+57%+19%
Industry peers (median)+9%+49%−6%−5%−1%+18%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
INVX50%50%67%25%67%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
INVX−54%−52%−42%−50%−30%−24%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 81% from February 27, 2017 to December 20, 2024. Getting back needed a 435% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$19.52 – $31.63
From 52-week high
−17.6%
vs 50-day average
−9.7%
vs 200-day average
−4.2%
Volatility (1 year)
45%
Beta vs S&P 500
0.75

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±7.2%
After a week
7 up, 4 down
typical move ±4.2%
After a month
5 up, 6 down
typical move ±7.9%
Results releasedNext dayS&P 500 next day5 days21 days
October 29, 2026 −7.5% −2.1% — —
August 3, 2026 +12.6% +3.3% +3.9% +7.7%
May 4, 2026 −3.6% +0.4% −2.3% −1.2%
February 23, 2026 +13.5% −0.3% +4.2% −2.9%
November 3, 2025 −2.3% −1.0% +3.4% +19.7%
August 5, 2025 +0.7% +0.3% +0.9% +8.0%
May 6, 2025 +0.9% −0.4% −0.7% −1.0%
April 25, 2025 −0.3% +0.8% −1.1% −10.6%
February 26, 2025 +18.3% −1.5% +8.9% +12.5%
February 25, 2025 +14.2% −0.4% +3.3% +9.3%
November 7, 2024 −0.8% +1.2% +2.3% −8.0%
August 1, 2024 −12.1% −3.3% −15.5% −5.8%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Innovex International, Inc.
$200M $400M $600M $800M $1B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $394.4M Revenue (TTM), FY23 Q4: $424.1M Revenue (TTM), FY24 Q1: $443.5M Revenue (TTM), FY24 Q2: $474.2M Revenue (TTM), FY24 Q3: $508.8M Revenue (TTM), FY24 Q4: $633.1M Revenue (TTM), FY25 Q1: $763.3M Revenue (TTM), FY25 Q2: $867.2M Revenue (TTM), FY25 Q3: $955.3M Revenue (TTM), FY25 Q4: $978.3M Revenue (TTM), FY26 Q1: $976.9M Revenue (TTM), FY26 Q2: $997.5M $997.5M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $394.4M
FY23 Q4 $424.1M
FY24 Q1 $443.5M
FY24 Q2 $474.2M
FY24 Q3 $508.8M
FY24 Q4 $633.1M
FY25 Q1 $763.3M
FY25 Q2 $867.2M
FY25 Q3 $955.3M
FY25 Q4 $978.3M
FY26 Q1 $976.9M
FY26 Q2 $997.5M
Revenue growth, TTM YoY Innovex International, Inc.
0% 50% 100% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 15.1% Revenue growth, TTM YoY, FY23 Q4: 17.2% Revenue growth, TTM YoY, FY24 Q1: 20.0% Revenue growth, TTM YoY, FY24 Q2: 29.8% Revenue growth, TTM YoY, FY24 Q3: 29.0% Revenue growth, TTM YoY, FY24 Q4: 49.3% Revenue growth, TTM YoY, FY25 Q1: 72.1% Revenue growth, TTM YoY, FY25 Q2: 82.9% Revenue growth, TTM YoY, FY25 Q3: 87.8% Revenue growth, TTM YoY, FY25 Q4: 54.5% Revenue growth, TTM YoY, FY26 Q1: 28.0% Revenue growth, TTM YoY, FY26 Q2: 15.0% 15.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 15.1%
FY23 Q4 17.2%
FY24 Q1 20.0%
FY24 Q2 29.8%
FY24 Q3 29.0%
FY24 Q4 49.3%
FY25 Q1 72.1%
FY25 Q2 82.9%
FY25 Q3 87.8%
FY25 Q4 54.5%
FY26 Q1 28.0%
FY26 Q2 15.0%
Operating margin (TTM) Innovex International, Inc.
0% 10% 20% 30% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 26.3% Operating margin (TTM), FY23 Q4: 12.8% Operating margin (TTM), FY24 Q1: 16.5% Operating margin (TTM), FY24 Q2: 17.4% Operating margin (TTM), FY24 Q3: 8.9% Operating margin (TTM), FY24 Q4: 7.8% Operating margin (TTM), FY25 Q1: 6.4% Operating margin (TTM), FY25 Q2: 6.7% Operating margin (TTM), FY25 Q3: 14.0% Operating margin (TTM), FY25 Q4: 13.6% Operating margin (TTM), FY26 Q1: 9.1% Operating margin (TTM), FY26 Q2: 10.0% 10.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 26.3%
FY23 Q4 12.8%
FY24 Q1 16.5%
FY24 Q2 17.4%
FY24 Q3 8.9%
FY24 Q4 7.8%
FY25 Q1 6.4%
FY25 Q2 6.7%
FY25 Q3 14.0%
FY25 Q4 13.6%
FY26 Q1 9.1%
FY26 Q2 10.0%
FCF margin (TTM) Innovex International, Inc.
5% 10% 15% 20% 25% 30% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 10.6% FCF margin (TTM), FY23 Q4: 10.2% FCF margin (TTM), FY24 Q1: 24.7% FCF margin (TTM), FY24 Q2: 26.3% FCF margin (TTM), FY24 Q3: 10.5% FCF margin (TTM), FY24 Q4: 9.8% FCF margin (TTM), FY25 Q1: 9.2% FCF margin (TTM), FY25 Q2: 11.4% FCF margin (TTM), FY25 Q3: 12.3% FCF margin (TTM), FY25 Q4: 13.3% FCF margin (TTM), FY26 Q1: 12.0% FCF margin (TTM), FY26 Q2: 9.4% 9.4%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 10.6%
FY23 Q4 10.2%
FY24 Q1 24.7%
FY24 Q2 26.3%
FY24 Q3 10.5%
FY24 Q4 9.8%
FY25 Q1 9.2%
FY25 Q2 11.4%
FY25 Q3 12.3%
FY25 Q4 13.3%
FY26 Q1 12.0%
FY26 Q2 9.4%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Innovex International took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $978M
  2. Cost of revenue $675M · 69.0%
  3. Gross profit $303M · 31.0%
  4. Research and development $6.7M · 0.7%
  5. Selling, general and admin $129M · 13.2%
  6. Other operating costs $35.2M · 3.6%
  7. Operating income $133M · 13.6%
  8. Income tax $45.2M · 4.6%
  9. Net income $83.3M · 8.5%

Shares of revenue. Source: Innovex International's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 540 566 601 733 872 931 844 539 455 385 415 365 322 362 424 661 978 998
Gross profit 230 244 239 281 358 417 385 210 125 91 120 95 13 53 64 233 303 323
EBITDA 160 160 153 188 253 310 279 145 −28 −87 37 −31 −95 94 120 80 193 163
Operating income 142 139 130 162 224 279 249 113 −69 −123 3 −64 −125 76 97 49 133 100
Net income 105 102 95 119 170 209 192 93 −101 −96 2 −31 −128 63 74 140 83 62
Diluted EPS $2.66 $2.55 $2.36 $2.94 $4.16 $5.19 $4.98 $2.47 −$2.69 −$2.58 $0.05 −$0.87 −$3.63 $2.01 $2.29 $2.77 $1.20 $0.89
Growth (year on year)
Revenue −0.5% +4.8% +6.2% +21.9% +19.0% +6.7% −9.3% −36.2% −15.5% −15.6% +7.8% −12.0% −11.7% +12.2% +17.2% +55.8% +48.0% +15.0%
EBITDA +0.9% −0.3% −4.3% +23.1% +34.6% +22.5% −9.9% −48.2% −119.5% — — −184.6% — — +27.2% −33.1% +140.9% +51.2%
Operating income +0.2% −2.3% −6.5% +24.7% +38.3% +24.7% −10.7% −54.6% −161.3% — — — — — +28.3% −49.6% +170.2% +71.8%
Net income −0.4% −2.8% −6.8% +25.1% +42.5% +22.9% −8.0% −51.4% −208.0% — — — — — +16.8% +89.8% −40.6% −57.4%
Diluted EPS +1.5% −4.1% −7.5% +24.6% +41.5% +24.8% −4.0% −50.4% −208.9% — — — — — +13.9% +21.0% −56.7% —
Margins
Gross margin 42.6% 43.0% 39.8% 38.4% 41.1% 44.8% 45.6% 39.0% 27.5% 23.7% 28.9% 26.1% 4.1% 14.6% 15.1% 35.2% 31.0% 32.4%
EBITDA margin 29.6% 28.2% 25.4% 25.6% 29.0% 33.3% 33.1% 26.9% −6.2% −22.7% 8.9% −8.5% −29.4% 26.1% 28.3% 12.1% 19.8% 16.4%
Operating margin 26.3% 24.5% 21.6% 22.1% 25.6% 29.9% 29.5% 20.9% −15.2% −31.9% 0.7% −17.4% −38.9% 21.0% 22.9% 7.4% 13.6% 10.0%
Net margin 19.5% 18.1% 15.8% 16.3% 19.5% 22.4% 22.7% 17.3% −22.1% −24.9% 0.4% −8.4% −39.8% 17.5% 17.4% 21.2% 8.5% 6.2%
Free-cash-flow margin 17.0% 5.7% 7.6% −8.0% 13.7% 11.5% 19.3% 41.0% 17.6% 3.5% 0.8% −9.1% 8.8% −6.8% 10.2% 14.1% 19.5% 15.8%
Cash flow
Cash from operations 136 107 102 −8 162 149 190 247 108 46 15 −21 38 −6 76 93 191 157
Capital spending 45 75 56 51 43 43 27 26 28 32 12 12 10 19 33 0 0 0
Free cash flow 92 32 46 −59 120 107 163 221 80 13 3 −33 28 −25 43 93 191 157
Stock-based pay 4 5 5 6 9 12 13 12 14 13 16 13 15 1 2 13 14 15
Free cash flow after stock pay 88 27 41 −65 111 95 150 209 66 −0 −13 −46 14 −26 41 80 177 143
Balance sheet
Cash 198 246 299 257 384 299 381 423 493 418 399 346 355 259 187 73 203 222
Total debt 1 0 0 — 0 0 0 0 0 0 0 0 0 0 50 35 26 25
Net debt (negative = net cash) −197 −246 −299 −257 −384 −299 −381 −423 −493 −418 −399 −346 −355 −259 −137 −38 −178 −197
Diluted shares 40m 40m 40m 41m 41m 40m 39m 38m 37m 37m 36m 35m 35m 31m 32m 51m 69m 69m
Returned to shareholders
Dividends — — — — — — — — — — — — — 0 0 75 0 —
Buybacks — — — — 10 190 76 24 0 100 27 25 24 21 0 0 9 14
Total returned — — — — 10 190 76 24 0 100 27 25 24 21 0 75 9 14

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

6 of 6 checks passed · June 30, 2026
What it owns · $1.3bn
Short-term assets $789mLonger-term assets $539m
What it owes, and who funded it · $1.3bn
Short-term liabilities $158mLonger-term liabilities $112mShareholders' equity $1.1bn
  • Short-term assets cover short-term liabilities $789m of assets due within a year against $158m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $789m short-term assets against $112m of longer-dated liabilities.
  • More cash than debt $222m of cash against $19m of debt.
  • Debt below 40% of shareholders' equity Debt is 2% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $157m of operating cash flow against $19m of debt.
  • Operating profit covers interest at least five times over Operating income of $100m against $290,000 of interest.

From Innovex International, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$14.1M
Returned to shareholders
15%
of free cash flow
Buybacks, last 3 fiscal years
$9.3M
Total shareholder yield
0.8%
dividends 0.0% + buybacks 0.8% of market value
Sales & admin spending
14.9%
of revenue
Days sales outstanding
88 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in oil & gas equipment & services
Last 12 months unless stated INVX AESI NOA TISI FET PUMP Median
Revenue, last 12 months $998m $1.1bn $919m $894m $874m $1.2bn $1.1bn
Revenue growth, last 12 months 15.0% −8.1% 8.0% 2.6% 10.6% −6.0% 4.2%
Revenue growth, 3-year average 39.8% 20.7% 26.2% 0.8% 5.5% −9.2% 3.4%
Revenue growth, latest quarter 9.2% 1.6% — −7.8% 20.7% 20.9% 8.7%
Gross margin 32.4% 7.1% 12.6% 24.7% 30.6% 24.3% 21.2%
Operating margin 10.0% −8.3% 8.5% 0.8% 7.4% 0.5% 7.4%
Operating margin, 3-year average 11.4% 7.0% 7.2% 0.5% −0.4% −3.9% 7.2%
Net margin 6.2% −11.1% 2.6% −3.7% 3.5% 0.2% 2.8%
Cash from operations / revenue 15.8% 5.1% 20.6% 1.4% 7.8% 16.1% 12.1%
Free-cash-flow margin 9.4% −17.2% −1.7% 0.1% 7.1% −7.9% 2.0%
Free-cash-flow margin, 3-year average 15.7% −14.3% 1.6% −0.6% 8.1% 1.1% 4.2%
Stock pay / revenue 1.5% 3.3% −0.0% 0.2% 1.2% 1.7% 1.1%
Change in share count −2.0% 6.8% −2.4% 1.5% −6.0% 21.0% 1.0%

Median of all 36 companies we cover in oil & gas equipment & services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $685M 70.1% ▲ 29.9%
Leasing $167M 17.0% ▲ 231.5%
Services $126M 12.9% ▲ 51.9%
Geography
Region Revenue Share YoY
US and Canadian Markets NAM $511M 52.3% ▲ 41.6%
United States $428M 83.8% ▲ 31.3%
East and Central Africa $81.6M 16.0% ▲ 128.1%
International and Offshore $467M 47.7% ▲ 55.8%
United States Offshore $112M 24.0% ▲ 31.2%
Other MEAP $103M 22.0% ▲ 65.8%
Canada $87M 18.6% ▲ 150.2%
SA $69.6M 14.9% ▲ 13.6%
Brazil $39.7M 8.5% ▲ 109.9%
Mexico $38M 8.1% ▲ 74.5%
AR $9.5M 2.0% ▲ 37.3%
Latin America $9.4M 2.0% ▲ 24.9%

From Innovex International, Inc.'s 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.3B
Institutions reporting
223
Shares held vs prior quarter
▲ 1.1%
Positions opened / closed
37 / 23

Top buyers and sellers, Q2 2026: 118 institutions bought and 93 sold ; the biggest buyer was Silvercrest Asset Management Group LLC (+929K shares) and the biggest seller Wellington Management Group LLP (−965K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $160M 6.5M 12.6% ▲ 7.1%
Brandes Investment Partners, LP $142M 5.7M 11.2% ▼ 13.0%
Dimensional Fund Advisors LP $71.3M 2.9M 5.6% ▲ 8.6%
Vanguard Portfolio Management LLC $68.3M 2.8M 5.4% ▲ 2.8%
Wellington Management Group LLP $66.7M 2.7M 5.2% ▼ 26.4%
Driehaus Capital Management LLC $48.6M 2.0M 3.8% ▲ 27.5%
Vanguard Capital Management LLC $47.3M 1.9M 3.7% ▼ 1.2%
State Street Corp $46.9M 1.9M 3.7% ▲ 10.2%
GAMCO Investors, Inc. Et Al $42.4M 1.7M 3.3% ▼ 1.4%
FMR LLC $30.2M 1.2M 2.4% ▼ 7.6%
Geode Capital Management, LLC $30M 1.2M 2.4% ▲ 28.4%
American Century Companies Inc $26.6M 1.1M 2.1% ▲ 53.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Innovex International, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $615M 30 trades by 6 insiders · 50% under pre-set plans
Net ▼ $615M net selling
Insider Date Trade Shares Price Value
Turowsky Jason Director August 10, 2026 Sell pre-set plan 176,944 $28.71 $5.1M
Turowsky Jason Director August 10, 2026 Sell pre-set plan 205,126 $28.71 $5.9M
Turowsky Jason Director August 10, 2026 Sell pre-set plan 865,508 $28.71 $24.8M
Turowsky Jason Director August 10, 2026 Sell pre-set plan 88 $28.71 $2,526
Turowsky Jason Director August 10, 2026 Sell pre-set plan 45,533 $28.71 $1.3M
Turowsky Jason Director August 10, 2026 Sell pre-set plan 3,706,801 $28.71 $106M
Intervale Capital Fund Iii, L.P. Director August 10, 2026 Sell 205,126 $28.71 $5.9M
Intervale Capital Fund Iii, L.P. Director August 10, 2026 Sell 3,706,801 $28.71 $106M
Intervale Capital Fund Iii, L.P. Director August 10, 2026 Sell 865,508 $28.71 $24.8M
Intervale Capital Fund Iii, L.P. Director August 10, 2026 Sell 176,944 $28.71 $5.1M
Intervale Capital Fund Iii, L.P. Director August 10, 2026 Sell 88 $28.71 $2,526
Intervale Capital Fund Iii, L.P. Director August 10, 2026 Sell 45,533 $28.71 $1.3M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 1 trade and filings

In the last 12 months, 1 member of Congress disclosed 0 purchases and 1 sale of Innovex International, Inc. shares.

  • Debbie Wasserman Schultz(D-FL 25):Sale (full), $1,140.00, traded November 25, 2025, filed December 8, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 25, 2027 estimated from the company's past filing pattern, not announced

  • October 29, 2026
  • August 3, 2026
  • May 4, 2026
  • February 23, 2026
  • November 3, 2025
  • August 5, 2025

Recent SEC filings

Data status

When each part of this page on Innovex International, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Innovex International, Inc. in brief

What does Innovex International, Inc. do?
Innovex International, Inc. is a US-listed company in the oil & gas equipment & services industry. Its financial year ends in December.
What is Innovex International, Inc.'s stock ticker?
Innovex International, Inc. trades under the ticker INVX on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Innovex International, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Innovex International, Inc. reported revenue of $998M, 15.0% higher than a year earlier, according to its SEC filings.
What is Innovex International, Inc.'s free cash flow?
Innovex International, Inc.'s free-cash-flow margin is 9.4% of revenue over the trailing twelve months.
Who are Innovex International, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Brandes Investment Partners, LP and Dimensional Fund Advisors LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Innovex International, Inc.'s market cap?
On November 2, 2026, Innovex International, Inc.'s market capitalisation was about $1.8B, with a price-to-earnings ratio of 29.3 and net debt of -$197M. Market figures come from third-party market data and may be delayed.
How much debt does Innovex International, Inc. have?
Innovex International, Inc.'s debt-to-equity ratio is 1.8%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Innovex International, Inc.'s competitors?
In our Oil & Gas Equipment & Services peer group, the companies closest to Innovex International, Inc. are Atlas Energy Solutions Inc., North American Construction Group Ltd., Team Inc, Forum Energy Technologies, Inc. and Propetro Holding Corp. The side-by-side comparison below sets their revenue, margins and growth against Innovex International, Inc.'s.
Are insiders buying or selling Innovex International, Inc. stock?
Over the last 12 months, Innovex International, Inc.'s directors and officers reported 0 open-market purchases and 30 sales on Form 4. The insider trading page charts every trade.
When is Innovex International, Inc.'s next earnings date?
Around January 25, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Innovex International, Inc. announces its own schedule.